Please login to the form below
Inovio
This page shows the latest Inovio news and features for those working in and with pharma, biotech and healthcare.
American Medical Association calls for COVID-19 vaccine development transparency
Organisation asks FDA to provide transparent information on review plans
Latest news
-
CEPI says $2bn is needed for COVID-19 vaccine development
CEPI has already invested $4.4m in partnering agreements with Novavax and The University of Oxford to rapidly develop COVID-19 vaccine candidates, and it also announced initial funding to Inovio
-
Trial backs Inovio/Sanofi combo in hard-to-treat brain cancer
Results at six months demonstrated 75% of patients were progression-free. A combination of three cancer immunotherapy drugs from Inovio and Sanofi/Regeneron has shown impressive results in glioblastoma multiforme (GBM), ... Newly-diagnosed GBM patients
-
Takeda gets FDA fast-track status for Zika vaccine
Last year Inovio Pharma and GeneOne Life Sciences reported phase I data with their synthetic GLS-5700 DNA vaccine in the New England Journal of Medicine (NEJM), concluding that it was
-
AZ adds cancer vaccine to immuno-oncology portfolio
AstraZeneca has signed a strategic-level licensing deal with Inovio for cancer vaccines that flesh out its cancer immunotherapy pipeline. ... The result is what Inovio claims is a 'best-in-class' T cell-stimulating therapy, generating fully functional
-
MERS-CoV deaths rise with few drugs in pipeline
Among the small number of companies developing potential vaccines against MERS are Inovio Pharmaceuticals and partner company GeneOne Life Sciences, which recently announced plans to start a phase I trial of
More from news
Approximately 2 fully matching, plus 10 partially matching documents found.
Latest Intelligence
-
COVID-19: the race to find a vaccine
Inovio Pharmaceuticals began testing its plasmid candidate in humans in April, putting it at the head of a pack of six groups that have DNA vaccines in development.
-
Developing a COVID-19 vaccine
The CEPI has currently initiated eight COVID-19 vaccine developments with Curevac, Inovio Pharmaceuticals, Moderna, Novavax, The University of Hong Kong, The University of Oxford, The University of Queensland and a
-
Deal Watch February 2017
Amendment to 2015 agreement. 80. Inovio Pharmaceuticals/ ApolloBio Corporation. VGX-3100, DNA immunotherapy to treat pre-cancers caused by human papillomavirus (phase II).
-
Pharma deals in August 2015
AstraZeneca deals. Subject. Headline $m. Inovio. Cancer vaccines. 727. Heptares. HTL 1071 and A2A receptor blocking compounds. ... Acquisition ‐ company. 847. Inovio. AZ/Medimmune. INO‐3112 vaccine in P1/2 for cervical and head &neck cancer.
-
Deal Watch table for September 2013
483. BioFire Diagnostics / BioMerieux. Acquisition. Invitro diagnostic company. 450. Inovio Pharma / Roche Holdings.
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- New medical communications agency BOLDSCIENCE launches
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- 20 for 2020 – Five pharma companies to watch
- Shionogi's Gram-negative antibiotic launches in the UK
- FDA approves Roche’s Actemra COVID-19 trial
- OPEN Health’s Digital team have won a Bronze Award at the PM Society Digital Awards 2020
- New restrictions announced as UK’s COVID-19 alert level is increased
- Keytruda plus chemotherapy cuts risk of death by 27% in advanced oesophageal cancer
- AZ/Merck's Lynparza improves survival in certain prostate cancers
- The flexible salesforce
- Navigating engagement and remote working during the pandemic
PMHub
Anthill Agency
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...
Latest intelligence
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
Quick links
Infographics
